MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment. Bartko EA, Mellergaard M, Groen SS, Nielsen SH, et al. Allergy 2024;79:2558-2561.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartko EA, Mellergaard M, Groen SS, Nielsen SH, et al. MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment. Allergy 2024;79:2558-2561.
PMID: 38953463